Emerging role of bystander T cell activation in autoimmune diseases

키워드

참고문헌 (66)

1. Kim J, "Innate-like cytotoxic function of bystander-activated CD8(+)T cells is associated with liver injury in acute hepatitis A", Immunity, 48, pp.161~173 (2018)
2. Lee HG, "Pathogenic function of bystander-activated memorylike CD4(+)T cells in autoimmune encephalomyelitis", Nat Commun, 10, pp.709~ (2019)
3. Simoni Y, "Bystander CD8(+)T cells are abundant and phenotypically distinct in human tumour infiltrates", Nature, 557, pp.575~579 (2018)
4. Tough DF, "Induction of bystander T cell proliferation by viruses and type I interferon in vivo", Science, 272, pp.1947~1950 (1996)
5. Tough DF, "T cell stimulation in vivo by lipopolysaccharide(LPS)", J Exp Med, 185, pp.2089~2094 (1997)
6. Gangappa S, "Bystander activation of CD4(+)T cells can represent an exclusive means of immunopathology in a virus infection", Eur J Immunol, 29, pp.3674~3682 (1999)
7. Yang HY, "Virus-induced polyclonal cytotoxic T lymphocyte stimulation", J Immunol, 142, pp.1710~1718 (1989)
8. Unutmaz D, "Antigen-independent activation of naive and memory resting T cells by a cytokine combination", J Exp Med, 180, pp.1159~1164 (1994)
9. Zarozinski CC, "Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response", J Exp Med, 185, pp.1629~1639 (1997)
10. Murali-Krishna K, "Counting antigen-specific CD8 T cells : a reevaluation of bystander activation during viral infection", Immunity, 8, pp.177~187 (1998)
11. Polley R, "The fate of heterologous CD4+ T cells during Leishmania donovani infection", Eur J Immunol, 35, pp.498~504 (2005)
12. Guo L, "IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells", Proc Natl Acad Sci U S A, 106, pp.13463~13468 (2009)
13. Guo L, "Innate immunological function of TH2 cells in vivo", Nat Immunol, 16, pp.1051~1059 (2015)
14. Pellicci DG, "Thymic development of unconventional T cells : how NKT cells, MAIT cells and γδ T cells emerge", Nat Rev Immunol, 20, pp.756~770 (2020)
15. Leite-De-Moraes MC, "A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement", J Immunol, 163, pp.5871~5876 (1999)
16. Terashima A, "A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity", J Exp Med, 205, pp.2727~2733 (2008)
17. Doisne JM, "Cutting edge : crucial role of IL-1 and IL-23 in the innate IL-17response of peripheral lymph node NK1. 1-invariant NKT cells to bacteria", J Immunol, 186, pp.662~666 (2011)
18. Ma R, "Immune effects of γδ T cells in colorectal cancer : a review", Front Immunol, 11, pp.1600~ (2020)
19. Haas JD, "CCR6 and NK1. 1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells", Eur J Immunol, 39, pp.3488~3497 (2009)
20. Kjer-Nielsen L, "MR1presents microbial vitamin B metabolites to MAIT cells", Nature, 491, pp.717~723 (2012)
21. Ussher JE, "CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner", Eur J Immunol, 44, pp.195~203 (2014)
22. van Wilgenburg B, "MAIT cells are activated during human viral infections", Nat Commun, 7, pp.11653~ (2016)
23. Swain SL, "Class II-independent generation of CD4 memory T cells from effectors", Science, 286, pp.1381~1383 (1999)
24. Eberl G, "Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation", J Immunol, 165, pp.4305~4311 (2000)
25. Chakir H, ""Bystander polarization"of CD4+ T cells : activation with high-dose IL-2 renders naive T cells responsive to IL-12and", or IL-18 in the absence of TCR ligation, 2003, pp.33, 1788~1798
26. Chung Y, "Critical regulation of early Th17 cell differentiation by interleukin-1signaling", Immunity, 30, pp.576~587 (2009)
27. Ben-Sasson SZ, "IL-1 acts on T cells to enhance the magnitude of in vivo immune responses", Cytokine, 56, pp.122~125 (2011)
28. Lee YK, "TCR-independent functions of Th17cells mediated by the synergistic actions of cytokines of the IL-12 and IL-1 families", PLoS One, 12, pp.e0186351~ (2017)
29. Jiang W, "Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation", J Virol, 88, pp.5369~5380 (2014)
30. van Aalst S, "Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant", PLoS One, 12, pp.e0177365~ (2017)
31. Zhang X, "Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15", Immunity, 8, pp.591~599 (1998)
32. Lu J, "Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes", Clin Cancer Res, 8, pp.3877~3884 (2002)
33. Tietze JK, "Delineation of antigen-specific and antigen-nonspecific CD8(+)memory T-cell responses after cytokine-based cancer immunotherapy", Blood, 119, pp.3073~3083 (2012)
34. Chu T, "Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner", Cell Rep, 3, pp.701~708 (2013)
35. Crosby EJ, "Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection", PLoS Pathog, 10, pp.e1003970~ (2014)
36. Younes SA, "IL-15promotes activation and expansion of CD8+ T cells in HIV-1 infection", J Clin Invest, 126, pp.2745~2756 (2016)
37. Seo IH, "IL-15 enhances CCR5-mediated migration of memory CD8(+)T cells by upregulating CCR5 expression in the absence of TCR stimulation", Cell Rep, 36, pp.109438~ (2021)
38. Lees JR, "Encephalitogenic T-cells increase numbers of CNS T-cells regardless of antigen specificity by both increasing T-cell entry and preventing egress", J Neuroimmunol, 220, pp.10~16 (2010)
39. Walsh JT, "MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4", J Clin Invest, 125, pp.699~714 (2015)
40. Van Kaer L, "Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE", Cell Mol Immunol, 16, pp.531~539 (2019)
41. Jones RE, "Nonmyelinspecific T cells accelerate development of central nervous system APC and increase susceptibility to experimental autoimmune encephalomyelitis", J Immunol, 170, pp.831~837 (2003)
42. Reynolds JM, "Toll-like receptor 2 signaling in CD4(+)T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease", Immunity, 32, pp.692~702 (2010)
43. Reynolds JM, "Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation", Proc Natl Acad Sci U S A, 109, pp.13064~13069 (2012)
44. Ferreira TB, "Different interleukin-17-secreting Toll-like receptor(+)T-cell subsets are associated with disease activity in multiple sclerosis", Immunology, 154, pp.239~252 (2018)
45. Nogai A, "Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells", J Immunol, 175, pp.959~966 (2005)
46. Tan LC, "Specificity of T cells in synovial fluid : high frequencies of CD8(+)T cells that are specific for certain viral epitopes", Arthritis Res, 2, pp.154~164 (2000)
47. Kobayashi M, "Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren’s syndrome", Arthritis Rheum, 50, pp.3974~3984 (2004)
48. Sobek V, "Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease", Arthritis Res Ther, 6, pp.R433~R446 (2004)
49. Brennan FM, "Resting CD4+ effector memory T cells are precursors of bystanderactivated effectors : a surrogate model of rheumatoid arthritis synovial T-cell function", Arthritis Res Ther, 10, pp.R36~ (2008)
50. Horwitz MS, "Diabetes induced by Coxsackie virus : initiation by bystander damage and not molecular mimicry", Nat Med, 4, pp.781~785 (1998)
51. Pane JA, "Lessons from the mouse : potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes", Diabetologia, 58, pp.1149~1159 (2015)
52. Simoni Y, "NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes", Eur J Immunol, 41, pp.3574~3585 (2011)
53. Markle JG, "γδ T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model", J Immunol, 190, pp.5392~5401 (2013)
54. Rouxel O, "Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes", Nat Immunol, 18, pp.1321~1331 (2017)
55. Lertmemongkolchai G, "Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens", J Immunol, 166, pp.1097~1105 (2001)
56. Doisne JM, "CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection", J Immunol, 173, pp.2410~2418 (2004)
57. Bastidas S, "CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals", J Immunol, 192, pp.1732~1744 (2014)
58. Nakamura R, "Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury", J Virol, 84, pp.5574~5582 (2010)
59. Gregorova M, "Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia", Elife, 9, pp.e63430~ (2020)
60. Joncker NT, "Antigen-independent accumulation of activated effector", memory, 2006, pp.118, 1205~1214
61. Duhen T, "Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors", Nat Commun, 9, pp.2724~ (2018)
62. Scheper W, "Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers", Nat Med, 25, pp.89~94 (2019)
63. Ponzetta A, "Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors", Cell, 178, pp.346~360 (2019)
64. Rosato PC, "Virusspecific memory T cells populate tumors and can be repurposed for tumor immunotherapy", Nat Commun, 10, pp.567~ (2019)
65. Danahy DB, "Cutting edge : antitumor immunity by pathogen-specific CD8 T cells in the absence of cognate antigen recognition", J Immunol, 204, pp.1431~1435 (2020)
66. Newman JH, "Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer", Proc Natl Acad Sci U S A, 117, pp.1119~1128 (2020)

관련 논문AI추천